Geode Capital Management, LLC Biotechnology

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AMRN Amarin Corp Plcuk	$190M	$92,000 0.0% of portfolio	147,010	Q3 2024 Reduced 34.24%
CGEN Compugen LTD	$139M	$91,000 0.0% of portfolio	50,395	Q1 2024 Added 24.19%
INDP Indaptus Therapeutics, Inc.	$8.09M	$90,000 0.0% of portfolio	73,129	Q3 2024 Added 23.3%
GLYC Glycomimetics Inc	$15.7M	$88,000 0.0% of portfolio	521,223	Q3 2024 Added 6.97%
INAB In8 Bio, Inc.	$8.09M	$88,000 0.0% of portfolio	329,274	Q3 2024 Added 3.75%
DRTS Alpha Tau Medical Ltd.	$207M	$85,000 0.0% of portfolio	35,716	Q3 2023 Added 7.98%
PRQR Pro Qr Therapeutics N.V.	$246M	$84,000 0.0% of portfolio	46,671	Q4 2023 Added 28.6%
INKT Mi Nk Therapeutics, Inc.	$22M	$73,000 0.0% of portfolio	97,981	Q3 2024 Added 1.7%
RPTX Repare Therapeutics Inc.	$151M	$65,000 0.0% of portfolio	19,128	Q3 2024 Reduced 27.94%
ONVO Organovo Holdings, Inc.	$3.75M	$63,000 0.0% of portfolio	125,479	Q3 2024 Added 13.7%
ORMP Oramed Pharmaceuticals Inc.	$95.5M	$62,000 0.0% of portfolio	25,455	Q4 2023 Added 21.74%
VIRX Viracta Therapeutics, Inc.	$6.38M	$57,000 0.0% of portfolio	250,007	Q3 2024 Reduced 7.67%
BYSI Beyond Spring Inc.	$67M	$55,000 0.0% of portfolio	24,368	Q1 2024 Added 20.74%
IFRX Infla Rx N.V.	$115M	$55,000 0.0% of portfolio	36,236	Q3 2023 Added 15.79%
IMMP Immutep LTD	$184M	$41,000 0.0% of portfolio	18,722	Q3 2021 Added 54.33%
CNTB Connect Biopharma Holdings LTD	$60.5M	$40,000 0.0% of portfolio	27,961	Q4 2023 Added 46.92%
VACC Vaccitech PLC	$127M	$39,000 0.0% of portfolio	11,568	Q4 2023 New
VIRI Virios Therapeutics, Inc.	$81.4M	$39,000 0.0% of portfolio	230,750	Q3 2024 Added 32.26%
ONCY Oncolytics Biotech Inc	$49.8M	$36,000 0.0% of portfolio	41,942	Q3 2023 Added 21.01%
IOBT Io Biotech, Inc.	$24.2M	$34,000 0.0% of portfolio	33,307	Q1 2024 Added 161.64%
ENTX Entera Bio Ltd.	$62.8M	$33,000 0.0% of portfolio	17,597	Q2 2021 New
SILO Silo Pharma, Inc.	$2.89M	$33,000 0.0% of portfolio	30,761	Q3 2024 Added 90.13%
IMAB I Mab	$88.1M	$27,000 0.0% of portfolio	22,037	Q3 2024 Reduced 35.84%
MIST Milestone Pharmaceuticals Inc.	$56.4M	$26,000 0.0% of portfolio	17,576	Q3 2021 Reduced 15.74%
ACHL Achilles Therapeutics PLC	$42.8M	$22,000 0.0% of portfolio	21,590	Q1 2022 Added 22.73%
ADAG Adagene Inc.	$110M	$22,000 0.0% of portfolio	10,309	Q1 2022 New
CLLS Cellectis S.A.	$88.3M	$22,000 0.0% of portfolio	10,776	Q1 2021 Reduced 0.18%
BLRX Bio Line Rx Ltd.	$15.4M	$21,000 0.0% of portfolio	39,993	Q4 2023 Added 24.88%
LVTX Lava Therapeutics Nv	$37.7M	$18,000 0.0% of portfolio	11,124	Q1 2022 Added 10.29%
ENLV Enlivex Therapeutics Ltd.	$23M	$17,000 0.0% of portfolio	10,420	Q3 2021 New
NRSN Neuro Sense Therapeutics Ltd.	$10.6M	$15,000 0.0% of portfolio	11,963	Q4 2023 New
IPA Immuno Precise Antibodies Ltd.	$9.93M	$11,000 0.0% of portfolio	17,484	Q4 2021 Added 20.61%
SLGL Sol Gel Technologies Ltd.	$11.8M	$9,000 0.0% of portfolio	13,406	Q1 2021 New
KZIA Kazia Therapeutics LTD	$59.7M	$6,000 0.0% of portfolio	14,784	Q3 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	1,234,805	Q3 2024 Added 3.26%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.